Skip to content
10-Q

Quarterly Report

Raphael Pharmaceutical Inc. RAPH

0001213900-23-065005

← back to feed
Filed
Aug 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 9, 2023 16.37M sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 $111K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $288K
Current Liabilities Q2 2023 · Jun 30, 2023 $180K
Current Liabilities Q2 2023 · Dec 31, 2022 $227K
Current Assets Q2 2023 · Jun 30, 2023 $118K
Current Assets Q2 2023 · Dec 31, 2022 $331K
Total Assets Q2 2023 · Jun 30, 2023 $119K
Total Assets Q2 2023 · Dec 31, 2022 $333K
Shares Diluted Q2 2023 · Jun 30, 2022 13.65M sh
Shares Diluted Q2 2023 · Jun 30, 2022 13.34M sh
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$330K
Stockholders Equity Q2 2023 · Jun 30, 2022 $118K
Stockholders Equity Q2 2023 · Mar 31, 2022 $103K
Stockholders Equity Q2 2023 · Dec 31, 2021 $128K
Eps Diluted Q2 2023 · Jun 30, 2022 $0.05
Eps Diluted Q2 2023 · Jun 30, 2022 $0.06
Eps Basic Q2 2023 · Jun 30, 2022 $0.05
Eps Basic Q2 2023 · Jun 30, 2022 $0.06
Sga Expense Q2 2023 · Jun 30, 2022 $528K
Sga Expense Q2 2023 · Jun 30, 2022 $617K
Rd Expense Q2 2023 · Jun 30, 2022 $84K
Rd Expense Q2 2023 · Jun 30, 2022 $170K
Net Income Q2 2023 · Jun 30, 2022 −$627K
Net Income Q2 2023 · Jun 30, 2022 −$812K
Net Income Q2 2023 · Mar 31, 2022 −$185K
Operating Income Q2 2023 · Jun 30, 2022 −$612K
Operating Income Q2 2023 · Jun 30, 2022 −$787K